PTH and Marchiafava-Bignami disease: Measurements of serum Ca, P, alkaline phosphatase (ALP), parathormon (PTH), urinary calcium or urinary phosphate excretion are used in clinical practice or are proposed as screening tests of MBD in preterm infants; however, the sensitivity and specificity of those tests are questionable [5–9].